I'm LongbridgeAI, I can summarize articles.In Thursday's pre-market session, healthcare stocks showed significant volatility. Gainers included Nuwellis (up 119%), GlucoTrack (+47.36%), and Corcept Therapeutics (+19.93%). Conversely, Capricor Therapeutics plummeted 56%, while Inovio Pharmaceuticals (-21.31%) and Teladoc Health (-20.16%) also declined sharply. Several moves were attributed to recent Q2 earnings releases.
Gainers
- Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.
- GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding shares is at $1.8 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 46.28% to $0.08. The company's market cap stands at $2.0 million.
- Corcept Therapeutics (NASDAQ:CORT) stock moved upwards by 19.93% to $111.48. The market value of their outstanding shares is at $9.9 billion. As per the press release, Q2 earnings came out yesterday.
- Mobile-health Network (NASDAQ:MNDR) stock moved upwards by 15.86% to $1.68. The company's market cap stands at $1.7 million.
- SL Science Holding (NASDAQ:SLBT) stock moved upwards by 15.38% to $3.0. The company's market cap stands at $1.4 billion.
Losers
- Capricor Therapeutics (NASDAQ:CAPR) stock fell 56.0% to $2.89 during Thursday's pre-market session.
- Inovio Pharmaceuticals (NASDAQ:INO) shares fell 21.31% to $0.82. The company's market cap stands at $85.5 million.
- Teladoc Health (NYSE:TDOC) shares fell 20.16% to $7.33. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q2 earnings came out yesterday.
- Pharming (NASDAQ:PHAR) shares declined by 16.74% to $10.0. The company's market cap stands at $848.2 million. As per the press release, Q2 earnings came out today.
- Biomerica (NASDAQ:BMRA) shares declined by 14.47% to $1.36. The market value of their outstanding shares is at $4.9 million.
- Advanced Biomed (NASDAQ:ADVB) stock decreased by 13.94% to $9.45. The market value of their outstanding shares is at $17.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.